Speciality: Oncology
Description:
Cancer treatments, such as chemotherapy, radiation, and immunotherapy, can cause a range of side effects. The most common include fatigue, nausea, hair loss, and changes in appetite. These side effects can be distressing, but they are often temporary and manageable. For example, medications can help reduce nausea, and dietitians can provide guidance on maintaining nutrition. Fatigue is often addressed through gentle exercise and rest, while support groups can help with emotional challenges. Hair loss, though common, is usually reversible after treatment. Each patient’s experience is unique, so healthcare teams work closely with individuals to tailor side effect management, aiming to improve comfort and quality of life throughout treatment.
See More Webinars @ Hidoc Webinars
1.
Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.
2.
According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.
3.
When Healthcare Chatbots Fall Short of Human Connection
4.
Even a few mutated cells can significantly impact how blood cancers develop, study finds
5.
Recently released national data on drug use and abuse among Americans.
1.
Understanding Bone Metastases: How Long Can Someone Live When Cancer Spreads To The Bones?
2.
The Ultimate Guide to Understanding Abiraterone and its Uses in Cancer Treatment
3.
Lymphomatoid Papulosis: What You Need to Know
4.
Transforming Cancer Care: Metrics, Informatics, Equity, and Real-World Evidence
5.
Bone Marrow Immune Niche Remodeling in Hematopoiesis
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Breast Cancer Awareness and Early Detection
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
4.
Common side effects of cancer treatment and how they are managed
5.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation